Form 4: Orchestra BioMed Holdings Executive Buys Shares
Insider Transaction (Form 4)
David P Hochman, See Remarks and a Director of Orchestra BioMed Holdings, Inc., purchased 10,000 shares of common stock on September 3, 2026 for $4.79 per share.
Summary
- Open-market purchase: acquired 10,000 Common Stock, par value $0.0001 per share ("Common Stock") at $4.79 ($47,900) on September 3, 2026; holds 1,070,746 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $47,900, committing personal capital to the stock.
Insider Transactions
David P Hochman — Director, Officer (See Remarks)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-03 | Open-market purchase | Common Stock, par value $0.0001 per share ("Common Stock") | 10,000 | $5 | $47.9K | 1,070,746 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-03 | Open-market purchase (10,000 shares) |
Keywords
insider transaction, Form 4, OBIO, Orchestra BioMed Holdings, Inc., bullish, David P Hochman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.